Severe aortic stenosis is a serious heart problem, the outlook for patients can be poorer than many cancers that have metastasized (e.g. lung and breast cancer). Without replacing the valve, patients who experience chest pain have an average life expectancy of 5 years, those with fainting an...
A sensitivity analysis was conducted to determine the impact of TAVR valve durability on life expectancy in younger age groups (40, 50, and 60 years). Results: Our cohort consisted of patients with aortic stenosis at low surgical risk with a mean age of 73.4 +/- 5.9 years. In the base-...
Severe aortic stenosis (AS) is the most common acquired valvular heart disease. Transcatheter aortic valve implantation (TAVI) is indicated as an alternative to surgery in patients (pts) with severe AS above 75 years old (yo) regardless of surgical risk. The prevalence of severe AS increases ...
valve area (AVA) <1 cm2 and/or index iAVA <0.6 cm2/m2 (consistent with severe AS) and the mean gradient (MG) <40 mmHg, consistent with mild/moderate AS. Accurate diagnosis of true severe low flow low gradient AS versus pseudo-severe aortic stenosis is important for prognosis...
A less common cause is rheumatic aortic disease, in which the valve is often regurgitant in addition to stenotic, and invariably associated with rheumatic disease of the mitral valve. Calcific aortic stenosis is a degenerative disease and its prevalence increases...
To our knowledge, this is the first study analyzing clinical efficacy and early safety of the novel BE nickel cobalt frame Myval THV, compared to the well-known SE supra-annular ER bioprosthesis, in patients undergoing TAVR for severe, symptomatic, native aortic valve stenosis. Our findings dem...